Single-cell transcriptomic and targeted genomic profiling adjusted for inflammation and therapy bias reveal CRTAM and PLCB1 as novel hub genes for anti-tumor necrosis factor alpha therapy response in Crohn’s disease
Year: 2024
Type: report
Study design: Observational Study
Abstract: The lack of reliable biomarkers in response to anti-TNFα biologicals hinders personalized therapy for Crohn’s disease (CD) patients. The motivation behind our study is to shift the paradigm of anti-TNFα biomarker discovery toward specific immune cell sub-populations using single-cell RNA sequencing and an innovative approach designed to uncover PBMCs gene expression signals, which may be masked due to the treatment or ongoing inflammation
Authors: Gorenjak, Mario, Gole, Boris, Goričan, Larisa, Jezernik, Gregor, Prosenc Zmrzljak, Uršula, Pernat Drobež, Cvetka, Skok, Pavel, Potočnik, Uroš
Institutions: University of Maribor, University Clinical Centre Maribor
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6987315497
